In details, reduced central tolerance to STL1 might induce and aggravate arthritis caused by cross-reactive autoantibody production45, and C1Q deficiency was prevalence in SLE patients while Anti-C1q antibodies was identified as a marker in SLE patients46, 47. Here, COL2A1 is linked to systemic lupus erythematosus.